{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T10:47:54Z","timestamp":1792838874317,"version":"4.5.0"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2740,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2008,3]]},"abstract":"<jats:sec>\n            <jats:title\/>\n            <jats:p>\n                                 <jats:bold>Abnormal liver tests occur in 3%\u20135% of pregnancies, with many potential causes, including coincidental liver disease (most commonly viral hepatitis or gallstones) and underlying chronic liver disease. However, most liver dysfunction in pregnancy is pregnancy-related and caused by 1 of the 5 liver diseases unique to the pregnant state: these fall into 2 main categories depending on their association with or without preeclampsia. The preeclampsia-associated liver diseases are preeclampsia itself, the hemolysis (H), elevated liver tests (EL), and low platelet count (LP) (HELLP) syndrome, and acute fatty liver of pregnancy. Hyperemesis gravidarum and intrahepatic cholestasis of pregnancy have no relationship to preeclampsia. Although still enigmatic, there have been recent interesting advances in understanding of these unique pregnancy-related liver diseases. Hyperemesis gravidarum is intractable, dehydrating vomiting in the first trimester of pregnancy; 50% of patients with this condition have liver dysfunction. Intrahepatic cholestasis of pregnancy is pruritus and elevated bile acids in the second half of pregnancy, accompanied by high levels of aminotransferases and mild jaundice. Maternal management is symptomatic with ursodeoxycholic acid; for the fetus, however, this is a high-risk pregnancy requiring close fetal monitoring and early delivery. Severe preeclampsia itself is the commonest cause of hepatic tenderness and liver dysfunction in pregnancy, and 2%\u201312% of cases are further complicated by hemolysis (H), elevated liver tests (EL), and low platelet count (LP)\u2014the HELLP syndrome. Immediate delivery is the only definitive therapy, but many maternal complications can occur, including abruptio placentae, renal failure, subcapsular hematomas, and hepatic rupture. Acute fatty liver of pregnancy is a sudden catastrophic illness occurring almost exclusively in the third trimester; microvesicular fatty infiltration of hepatocytes causes acute liver failure with coagulopathy and encephalopathy. Early diagnosis and immediate delivery are essential for maternal and fetal survival.<\/jats:bold>\n                              <\/jats:p>\n          <\/jats:sec>","DOI":"10.1002\/hep.22130","type":"journal-article","created":{"date-parts":[[2008,2,8]],"date-time":"2008-02-08T21:46:21Z","timestamp":1202507181000},"page":"1067-1076","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":260,"title":["Liver disease in pregnancy"],"prefix":"10.1097","volume":"47","author":[{"given":"Eileen J.","family":"Hay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-33-20241201","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1136\/gut.51.6.876","article-title":"Prospective study of liver dysfunction in pregnancy in Southwest Wales.","volume":"51","author":"Chng","year":"2002","journal-title":"Gut"},{"key":"R2-33-20241201","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1136\/pmj.78.916.76","article-title":"Hyperemesis gravidarum: current concepts and management.","volume":"78","author":"Kuscu","year":"2002","journal-title":"Postgrad Med J"},{"key":"R3-33-20241201","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/01.AOG.0000195059.82029.74","article-title":"Risk factors for hyperemesis gravidarum requiring hospital admission during pregnancy.","volume":"107","author":"Fell","year":"2006","journal-title":"Obstet Gnecol"},{"key":"R4-33-20241201","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1002\/hep.20473","article-title":"Glutathione Stransferase and liver function in intrahepatic cholestasis of pregnancy and pruritus gravidarum.","volume":"40","author":"Dann","year":"2004","journal-title":"HEPATOLOGY"},{"key":"R5-33-20241201","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1093\/hmg\/9.8.1209","article-title":"Heterozygous MDR3 missense mutation associated with intrahepatic cholestasis of pregnancy: evidence for a defect in protein trafficking.","volume":"9","author":"Dixon","year":"2000","journal-title":"Hum Mol Genet"},{"key":"R6-33-20241201","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/hep.21500","article-title":"Linkage between a new splicing site mutation in the MDR3 alias ABCB4 gene and intrahepatic cholestasis of pregnancy.","volume":"45","author":"Schneider","year":"2007","journal-title":"HEPATOLOGY"},{"key":"R7-33-20241201","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1053\/j.gastro.2006.05.003","article-title":"Combined mutations of canalicular transporter proteins cause severe intrahepatic cholestasis of pregnancy.","volume":"131","author":"Keitel","year":"2006","journal-title":"Gastroenterology"},{"key":"R8-33-20241201","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1111\/j.1365-2036.2006.02869.x","article-title":"Intrahepatic cholestasis of pregnancy; three novel MDR3 gene mutations.","volume":"23","author":"Floreani","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"R9-33-20241201","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/S0168-8278(00)80214-7","article-title":"Selenium, zinc and copper plasma levels in intrahepatic cholestasis of pregnancy, in normal pregnancies and in healthy individuals, in Chile.","volume":"32","author":"Reyes","year":"2000","journal-title":"J Hepatol"},{"key":"R10-33-20241201","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/hep.20336","article-title":"Intrahepatic cholestasis of pregnancy: relationships between bile acid levels and fetal complication rates.","volume":"40","author":"Glantz","year":"2004","journal-title":"HEPATOLOGY"},{"key":"R11-33-20241201","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1053\/jhep.2001.22647","article-title":"Ursodeoxycholic acid administration in patients with cholestasis of pregnancy: effects on primary bile acids in babies and mothers.","volume":"33","author":"Mazzella","year":"2001","journal-title":"HEPATOLOGY"},{"key":"R12-33-20241201","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1053\/j.gastro.2005.06.019","article-title":"Efficacy and safety of ursodeoxycholic acid versus cholestyramine in intrahepatic cholestasis of pregnancy.","volume":"129","author":"Kondrackiene","year":"2005","journal-title":"Gastroenterology"},{"key":"R13-33-20241201","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1002\/hep.20952","article-title":"Intrahepatic cholestasis of pregnancy: a randomized controlled trial comparing dexamethasone and ursodeoxycholic acid.","volume":"42","author":"Glantz","year":"2005","journal-title":"HEPATOLOGY"},{"key":"R14-33-20241201","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1515\/JPM.2006.077","article-title":"Randomized prospective comparative study of ursodeoxycholic acid and SadenosylLmethionine in the treatment of intrahepatic cholestasis of pregnancy.","volume":"34","author":"Binder","year":"2006","journal-title":"J Perinat Med"},{"key":"R15-33-20241201","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/hep.21111","article-title":"Intrahepatic cholestasis of pregnancy as an indicator of liver and biliary diseases: a populationbased study.","volume":"43","author":"Ropponen","year":"2006","journal-title":"HEPATOLOGY"},{"key":"R16-33-20241201","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1097\/01.ogx.0000146948.19308.c5","article-title":"HEELP syndrome: the state of the art.","volume":"59","author":"Baxter","year":"2004","journal-title":"Obstet Gynecol Surg"},{"key":"R17-33-20241201","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.clp.2004.06.008","article-title":"Diagnosis and management of hemolysis, elevated liver enzymes, and low platelets syndrome.","volume":"31","author":"Barton","year":"2004","journal-title":"Clin Pernatol"},{"key":"R18-33-20241201","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1097\/01.AOG.0000258281.22296.de","article-title":"Imitators of severe preeclampsia.","volume":"109","author":"Sibai","year":"2007","journal-title":"Obstet Gynecol"},{"key":"R19-33-20241201","doi-asserted-by":"crossref","first-page":"7397","DOI":"10.3748\/wjg.v12.i46.7397","article-title":"Acute fatty liver of pregnancy: an update on pathogenesis and clinical implications.","volume":"46","author":"Ibdah","year":"2006","journal-title":"World J Gastroenterol"},{"key":"R20-33-20241201","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1097\/01.AOG.0000126245.35811.2a","article-title":"Diagnosis, controversies, and management of the syndrome of hemolysis, elevated liver enzymes, and low platelet count.","volume":"103","author":"Sibai","year":"2004","journal-title":"Obstet Gynecol"},{"key":"R21-33-20241201","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/01.ogx.0000150346.42901.07","article-title":"Corticosteroids, pregnancy, and HELLP syndrome: a review.","volume":"60","author":"Van Runnard Heimel","year":"2004","journal-title":"Obstet Gynecol Surg"},{"key":"R22-33-20241201","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/lt.20285","article-title":"Liver transplantation for HELLP syndrome.","volume":"11","author":"Shames","year":"2005","journal-title":"Liver Transpl"},{"key":"R23-33-20241201","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S1089-3261(05)70054-4","article-title":"Acute fatty liver of pregnancy.","volume":"3","author":"Reyes","year":"1999","journal-title":"Clin Liver Dis"},{"key":"R24-33-20241201","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/01.AOG.0000191297.47183.bd","article-title":"Fetal fatty acid oxidation defects and maternal liver disease in pregnancy.","volume":"107","author":"Borwning","year":"2006","journal-title":"Obstet Gynecol"},{"key":"RU25-33-20241201","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1016\/j.ajog.2004.12.035","article-title":"Acute fatty liver of pregnancy in 3 tertiary care centers.","volume":"192","author":"Fesenmeier","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"R26-33-20241201","first-page":"34","article-title":"An overview of expanded newborn screening for inborn errors of metabolism.","volume":"41","author":"Goodin","year":"2006","journal-title":"Practical Gastroenterol"},{"key":"R27-33-20241201","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.adnc.2003.12.001","article-title":"Maternal acute fatty liver of pregnancy and the associated risk for longchain 3hydroxyacylcoenzyme A dehydrogenase (LCHAD) deficiency in infants.","volume":"4","author":"Bellig","year":"2004","journal-title":"Adv Neonatal Care"},{"key":"R28-33-20241201","first-page":"205","article-title":"Viral hepatitis in pregnancy.","volume":"6","author":"Hay","year":"2000","journal-title":"Viral Hepatitis Reviews"},{"key":"R29-33-20241201","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.cgh.2006.05.016","article-title":"A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: an update.","volume":"4","author":"Keefe","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R30-33-20241201","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/hep.20534","article-title":"Incidence, natural history, and risk factors for biliary sludge and stones during pregnancy.","volume":"41","author":"Ko","year":"2005","journal-title":"HEPATOLOGY"},{"key":"R31-33-20241201","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S1089-3261(05)70058-1","article-title":"Biliary tract disease in pregnancy.","volume":"3","author":"Yates","year":"1999","journal-title":"Clin Liver Dis"},{"key":"R32-33-20241201","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.amjsurg.2004.09.002","article-title":"Medical versus surgical management of biliary tract disease in pregnancy.","volume":"188","author":"Lu","year":"2004","journal-title":"Am J Surg"},{"key":"R33-33-20241201","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s00464-003-8811-8","article-title":"Laparoscopy for appendicitis and cholelithiasis during pregnancy.","volume":"18","author":"Rollins","year":"2004","journal-title":"Surg Endosc"},{"key":"R34-33-20241201","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.semarthrit.2005.03.002","article-title":"Autoimmune hepatitis and pregnancy: a rheumatologists dilemma.","volume":"35","author":"Candia","year":"2005","journal-title":"Semin Arthritis Rheum"},{"key":"R35-33-20241201","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1056\/NEJM198707233170405","article-title":"The use of trientine in preventing the effects of interrupting penicillamine therapy in Wilsons disease.","volume":"317","author":"Scheinberg","year":"1987","journal-title":"N Engl J Med"},{"key":"R36-33-20241201","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1053\/j.gastro.2006.04.049","article-title":"American gastroenterological association institute technical review on The use of gastrointestinal medications in pregnancy.","volume":"131","author":"Mahadevan","year":"2006","journal-title":"Gastroenterology"},{"key":"R37-33-20241201","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1002\/lt.20851","article-title":"Pregnancy after liver transplantation.","volume":"12","author":"Armenti","year":"2006","journal-title":"Liver Transpl"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.22130","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01515467-200803000-00033","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T13:15:32Z","timestamp":1733058932000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01515467-200803000-00033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.22130","relation":{},"ISSN":["0270-9139"],"issn-type":[{"value":"0270-9139","type":"print"}],"subject":[],"published":{"date-parts":[[2008,3]]}}}